Enterprise Life Sciences Research Platforms sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Enterprise Life Sciences Research Platforms
1.1 - About Enterprise Life Sciences Research Platforms sector
Companies in this category provide integrated lab software and platform tools for life sciences R&D. Their systems unify sample tracking, protocols, instrument data, and analysis to streamline discovery and development. By standardizing workflows, enabling compliant data capture, and connecting wet lab and computational processes, Enterprise Life Sciences Research Platforms help customers accelerate experiments, improve reproducibility, and scale research operations across sites and teams.
These vendors typically offer Laboratory Information Management Systems that manage specimens and chain-of-custody, Electronic Lab Notebooks for protocol capture, assay development and data analysis software, bioinformatics pipelines for genomics and proteomics, instrument connectivity for automated data ingestion, workflow automation and robotics control, quality and compliance management with audit trails, and reporting and visualization modules that surface results and KPIs for scientific and operational stakeholders.
Primary customers include biopharma R&D groups, contract research and manufacturing organizations, and academic and clinical laboratories. Outcomes typically include faster study startup and cycle times, higher data integrity and regulatory compliance, improved throughput via instrument orchestration and automation, and lower operating costs through standardized workflows and streamlined collaboration across teams, sites, and external partners.
2. Buyers in the Enterprise Life Sciences Research Platforms sector
2.1 Top strategic acquirers of Enterprise Life Sciences Research Platforms companies
Thermo Fisher Scientific
HQ: United States
Website
- Description: Provider of scientific services offering integrated CDMO-CRO drug development and clinical trial solutions, laboratory instrument maintenance and compliance, cell biology and custom manufacturing services, enterprise-level lab informatics, training, financing and licensing support to boost research productivity and efficiency across life-science, pharma and industrial laboratories.
- Key Products:
- Integrated CDMO-CRO Services: Delivers end-to-end drug substance and product manufacturing for small and large molecules, advanced therapies plus clinical supply, research and commercialization support, streamlining development cycles
- Lab Instruments & Equipment Services: Provides instrument service and maintenance plans alongside compliance, validation and calibration programs ensuring operational uptime and regulatory readiness for environmental and process monitoring devices
- Cell Biology Services: Offers genome editing, custom media, cell line engineering, antibody production and viral vector services enabling researchers to accelerate project goals and create tailored life-saving research solutions
- Enterprise Services (Unity Lab Services): Supplies integrated asset and supply management, lab consulting and scientific support services that increase enterprise productivity, cut costs and simplify laboratory support across organizations.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Enterprise Life Sciences Research Platforms sector
M&A buyer group 1: LIMS
4 companies
View group →
Description: Companies in the Enterprise Life Sciences LIMS Platforms category build software that orchestrates end‑to‑end laboratory operations for research, development, and regulated testing. Their systems centralize sample data, standardize workflows, and provide auditable traceability from accessioning through results reporting. By connecting instruments, people, and processes, these vendors help life sciences organizations improve data integrity, compliance, and throughput while reducing cycle times across multi‑site labs.
Elemental Machines
- Type: N/A
- Employees: ●●●●●
- Description: Provider of an intelligent operations platform that integrates IoT sensors, custom hardware and software to give labs, biopharma and manufacturing sites real-time monitoring, predictive analytics and actionable insights, transforming equipment oversight, compliance and operational efficiency from reactive to proactive.
- Key Products:
- Intelligent Operations Platform: IoT-connected hardware, sensors and software collect high-sample-rate data, unify physical-digital worlds and provide actionable insights that simplify, optimize and augment laboratory and manufacturing operations
- AI-Driven Predictive Analytics: Contextual anomaly detection, custom AI models and proactive maintenance insights forecast issues, reduce downtime and extend equipment lifespan while displaying real-time data in user-friendly dashboards
- Freezer Monitoring Solutions: Continuous cold-storage monitoring with alerts ensures freezer health, protects samples during off-hours and safeguards compliance for life-science laboratories
- Custom Dashboards: Highly configurable dashboards let users combine multiple data sources, monitor key metrics in real-time, tailor insights to workflows and simplify data-driven decision-making across environmental and utilization parameters.
🔒
🔒
🔒
View all 4 companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms in Enterprise Life Sciences Research Platforms sector
3.1 - Buyout funds in the Enterprise Life Sciences Research Platforms sector
2.2 - Strategic buyer groups for Enterprise Life Sciences Research Platforms sector
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Enterprise Life Sciences Research Platforms companies
4.2 - Public trading comparable groups for Enterprise Life Sciences Research Platforms sector
Valuation benchmark group 1: Industry-Specific SaaS Companies
13 companies
View group →
Description: Companies in this public trading comparables group provide industry‑specific, mission‑critical software delivered primarily via the cloud. Their business model centers on recurring subscription revenue augmented by maintenance and professional services, and in some cases hardware-enabled platforms. They are grouped as valuation benchmarks because they address vertical workflows with high switching costs, durable customer relationships, and predictable growth profiles typical of vertical market software.
Constellation Software
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of software and services to public and private sector markets, specializing in acquiring, managing, and building industry-specific software businesses that offer mission-critical solutions to meet unique customer needs.
- Key Products:
- Vertical Market Software: Industry-specific software tailored to meet unique sector needs
- Mission-Critical Solutions: Software that addresses essential business operations
- Managed Services: Comprehensive management of software and IT infrastructure
- Software Licensing: Licensing solutions for various industries
- System Integration: Integration of disparate systems for seamless operations
🔒
🔒
🔒
View all 13 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →